ASNDASCENDIS PHARMA A/S
CUSIP K08588103 · common stock
5 tracked investors held ASCENDIS PHARMA A/S (ASND) at the end of Q3 2026, worth $2.6B in total. The largest holder was RA Capital Management, with 23.5% of its portfolio. 2 investors opened new positions this quarter, including Joel Greenblatt.
Holders · Q3 2026
5
New holders
2
Value held
$2.6B
Quarter-end price (est.)
$227.83
Investors holding ASND · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 23.50% | 10,281,496 | $2.3B | HOLD |
| Perceptive Advisors Perceptive Advisors LLC | 3.86% | 971,521 | $221.3M | REDUCE-16.5% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.03% | 58,816 | $13.4M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.28% | 28,604 | $6.5M | HOLD |
| Polen Capital Management Polen Capital Management LLC | 0.05% | 21,860 | $5M | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Ron Baron | 0.00% | 1,500 | $400.1K | EXIT |